Karuna Therapeutics to Present at Upcoming Investor Conferences
July 30 2020 - 6:30AM
Business Wire
Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative
clinical-stage biopharmaceutical company committed to developing
novel therapies with the potential to transform the lives of people
with disabling and potentially fatal neuropsychiatric disorders and
pain, today announced that senior management will participate in
the following upcoming virtual investor conferences:
William Blair’s Biotech Focus Conference Date: Thursday,
August 6, 2020 Time: 10:00 a.m. EDT
Wedbush PacGrow Healthcare Virtual Conference Date:
Tuesday, August 11, 2020 Time: 10:55 a.m. EDT
Canaccord Genuity 40th Annual Growth Conference Date:
Wednesday, August 12, 2020 Time: 4:00 p.m. EDT
JMP Securities CNS Forum Date: Wednesday, August 19, 2020
Time: 11:30 a.m. EDT
A live webcast of the Wedbush presentation will be available on
the Investor Relations page of Karuna’s website at
investors.karunatx.com. A replay of the webcast will also be
archived for up to 90 days on Karuna’s website following the
conference.
About Karuna
Karuna is a clinical-stage biopharmaceutical company committed
to developing and delivering first-in-class therapies with the
potential to transform the lives of people with CNS disorders –
which remain among the most disabling and potentially fatal
disorders worldwide. Galvanized by the understanding that today’s
neuropsychiatric and pain management patients deserve better,
Karuna’s mission is to harness the untapped potential of the
brain’s complex biology in pursuit of novel therapeutic pathways
that will advance the standard of care. For more information,
please visit karunatx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200730005169/en/
Investor Contact Alexis Smith 518-338-8990
asmith@karunatx.com
Karuna Therapeutics (NASDAQ:KRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Karuna Therapeutics (NASDAQ:KRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024